Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Adult Acute Lymphoblastic Leukemia in Remission
- Adult Acute Myeloid Leukemia in Remission
- Adult Hodgkin Lymphoma
- Adult Non-Hodgkin Lymphoma
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Cytomegaloviral Infection
- Hematopoietic and Lymphoid Cell Neoplasm
- HLA-A*0201 Positive Cells Present
- Myelodysplastic Syndrome
- Adult Lymphoblastic Lymphoma
- Chronic Lymphocytic Leukemia
- Myelofibrosis
- Myeloproliferative Neoplasm
Interventions
- BIOLOGICAL: CMVpp65-A*0201 peptide vaccine
- OTHER: Placebo
- OTHER: Laboratory Biomarker Analysis
Sponsor
City of Hope Medical Center
Collaborators